Cue biopharma to present at the upcoming jmp securities life sciences conference

Cambridge, mass., june 14, 2021 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted t cells directly within the patient's body, announced today that it will take part in a fireside chat at the jmp securities life sciences conference being held june 16-17, 2021.
CUE Ratings Summary
CUE Quant Ranking